|
|
|
On this week's episode of the Business of Biotech, Paul Hastings, Founding CEO and Board Member at Nkarta, an allogeneic cell therapy developer, talks about building off-the-shelf CAR NK cell therapies for autoimmune disease. |
|
|
|
|
|
|
|
|
| Connect With Life Science Leader: |
|
|
|